A US pharmaceutical giant has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted as a potential treatment for COVID-19.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2TRentm
No comments:
Post a Comment